Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation - Restricted Stock (Details)

v3.21.1
Stock Based Compensation - Restricted Stock (Details) - Restricted Stock
3 Months Ended
Mar. 31, 2021
$ / shares
shares
Number of Shares  
Equity instruments outstanding, beginning balance (in shares) | shares 1,377,889
RSUs granted during period (in shares) | shares 230,373
RSUs vested during period (in shares) | shares (299,039)
RSUs forfeited during period (in shares) | shares 0
Equity instruments outstanding, ending balance (in shares) | shares 1,309,223
Weighted Average Grant Date Fair Value per Share  
Weighted average grant date fair value, RSUs outstanding, beginning balance (in usd per share) | $ / shares $ 2.70
Weighted average grant date fair value, RSUs outstanding, granted during period (in usd per share) | $ / shares 15.28
Weighted average grant date fair value, RSUs outstanding, vested during period (in usd per share) | $ / shares 2.73
Weighted average grant date fair value, RSUs outstanding, forfeited during period (in usd per share) | $ / shares 0
Weighted average grant date fair value, RSUs outstanding, ending balance (in usd per share) | $ / shares $ 4.94